While we’re still far away from finding an actual cure for cancer, it’s undeniable that the world has made progress in ...
Dr. Richard Rovin, a neurosurgeon at Aurora St. Lukes Medical Center in Milwaukee came home from work in 2002 and his wife, a ...
March 24 () - The European Union's medicines regulator said on Tuesday it expects Baxter International's cancer drugs ...
A new experimental drug is showing potential in treating prostate cancer and possibly other forms of the disease.
Philip 'Pip' Harding was sitting down to supper with his wife Claire one evening just over two years ago when, out of the ...
Stocktwits on MSN
IBRX stock rises premarket: Anktiva moves into pre-surgery pancreatic cancer combo trial with Bristol Myers drug
Founder Patrick Soon-Shiong said Abraxane from Bristol Myers Squibb could help boost immune responses when combined with the ...
Johnson & Johnson (NYSE:JNJ) ranks among the best most active stocks to buy right now. On March 13, Johnson & Johnson ...
A research team from the Department of Pathology, School of Clinical Medicine, LKS Faculty of Medicine of the University of ...
UIC researchers have successfully repurposed an FDA-approved cancer drug, doxorubicin, to treat drug-resistant strains of herpes. Their work appears in the journal Drug Resistance Updates.
Just one day after its stock soared in response to Macau's approval of its oncology drug Anktiva® as a treatment for certain ...
Vermont Business Magazine The University of Vermont Cancer Center is the first in Vermont to begin using a revolutionary new ...
A technique that transforms immune cells into cancer-seeking bloodhounds may overcome a roadblock that has hampered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results